TY - JOUR
T1 - Support for pharmacist-provided HPV vaccination
T2 - National surveys of U.S. Physicians and parents
AU - Shah, Parth D.
AU - Calo, William A.
AU - Marciniak, Macary W.
AU - Gilkey, Melissa B.
AU - Brewer, Noel T.
N1 - Funding Information:
N.T. Brewer is the chair of the National HPV Vaccination Roundtable at the American Cancer Society/CDC; reports receiving commercial research funding from Merck, Pfizer, and CDC; and is a consultant/advisory board member for Merck. No potential conflicts of interest were disclosed by the other authors.
Funding Information:
This study was supported in part by a research grant from Pfizer and the Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp. P.D. Shah is partially supported by a National Research Service Award Postdoctoral Traineeship from the Agency for Healthcare Research and Quality sponsored by The Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill (Grant No. T32-HS000032).
Funding Information:
Research, The University of North Carolina at Chapel Hill (Grant No. T32-HS000032).
Funding Information:
This study was supported in part by a research grant from Pfizer and the Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp. P.D. Shah is partially supported by a National Research Service Award Postdoctoral Traineeship from the Agency for Healthcare Research and Quality sponsored by The Cecil G. Sheps Center for Health Services
Publisher Copyright:
© 2018 American Association for Cancer Research.
PY - 2018/8
Y1 - 2018/8
N2 - Background: State laws about pharmacists providing human papillomavirus (HPV) vaccines vary considerably, limiting many pharmacists' ability to provide this important cancer prevention service. We characterized physician and parent support for pharmacist-provided HPV vaccination for adolescents who are past due for vaccination. Methods: In 2014 to 2015, we conducted two national U.S. surveys of 776 primary care physicians (PCPs) and 1,504 parents of adolescents. Respondents indicated the extent to which they supported pharmacist-provided HPV vaccination for 13- to 17-year-olds who are past due. Respondents could endorse the provision unconditionally, or only if certain conditions were met, such as pharmacists receiving proper vaccination training. We used multivariable logistic regression to assess correlates of support. Results: Most physicians (79%) and parents (81%) endorsed pharmacist-provided HPV vaccination if pharmacists had received proper vaccination training, reported vaccine doses to adolescents' PCP, and referred adolescents to PCPs for other health services. Family medicine physicians were more likely than pediatricians to support trained pharmacists providing HPV vaccination [OR ¼ 1.62; 95% confidence interval (CI) 1.17–2.22]. Support was also higher among physicians who practiced in Western states (OR ¼ 2.11; 95% CI, 1.30–3.40). Parents' odds of endorsing trained pharmacists provision of HPV vaccine increased with higher overall satisfaction with their pharmacy's services (OR ¼ 1.10; 95% CI, 1.02–1.19), belief in pharmacists' competence in vaccination practices (OR ¼ 1.42; 95% CI, 1.18–1.70), and overall vaccine confidence (OR ¼ 1.30; 95% CI, 1.15–1.48). Conclusions: To increase support for HPV vaccination services, pharmacists should raise awareness about their immunization training and standardize vaccination protocols that ensure coordination with primary care. Impact: Stakeholders' feedback and buy-in is important to help guide expansion of HPV vaccination in pharmacies.
AB - Background: State laws about pharmacists providing human papillomavirus (HPV) vaccines vary considerably, limiting many pharmacists' ability to provide this important cancer prevention service. We characterized physician and parent support for pharmacist-provided HPV vaccination for adolescents who are past due for vaccination. Methods: In 2014 to 2015, we conducted two national U.S. surveys of 776 primary care physicians (PCPs) and 1,504 parents of adolescents. Respondents indicated the extent to which they supported pharmacist-provided HPV vaccination for 13- to 17-year-olds who are past due. Respondents could endorse the provision unconditionally, or only if certain conditions were met, such as pharmacists receiving proper vaccination training. We used multivariable logistic regression to assess correlates of support. Results: Most physicians (79%) and parents (81%) endorsed pharmacist-provided HPV vaccination if pharmacists had received proper vaccination training, reported vaccine doses to adolescents' PCP, and referred adolescents to PCPs for other health services. Family medicine physicians were more likely than pediatricians to support trained pharmacists providing HPV vaccination [OR ¼ 1.62; 95% confidence interval (CI) 1.17–2.22]. Support was also higher among physicians who practiced in Western states (OR ¼ 2.11; 95% CI, 1.30–3.40). Parents' odds of endorsing trained pharmacists provision of HPV vaccine increased with higher overall satisfaction with their pharmacy's services (OR ¼ 1.10; 95% CI, 1.02–1.19), belief in pharmacists' competence in vaccination practices (OR ¼ 1.42; 95% CI, 1.18–1.70), and overall vaccine confidence (OR ¼ 1.30; 95% CI, 1.15–1.48). Conclusions: To increase support for HPV vaccination services, pharmacists should raise awareness about their immunization training and standardize vaccination protocols that ensure coordination with primary care. Impact: Stakeholders' feedback and buy-in is important to help guide expansion of HPV vaccination in pharmacies.
UR - http://www.scopus.com/inward/record.url?scp=85050929088&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050929088&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-18-0380
DO - 10.1158/1055-9965.EPI-18-0380
M3 - Review article
C2 - 29871883
AN - SCOPUS:85050929088
SN - 1055-9965
VL - 27
SP - 970
EP - 978
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 8
ER -